Nasogastric Tube and Orogastric Tube Market Outlook, Trends & Forecast 2033

Nasogastric Tube and Orogastric Tube by Application (Children Use, Adult Use), by Types (Flexible Tube, Rigid Tube, Semi-Rigid Tube), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Nasogastric Tube and Orogastric Tube Market Size | CAGR 6.2 Forecast 2033

Nasogastric Tube and Orogastric Tube Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Nasogastric Tube and Orogastric Tube Market Overview

The Nasogastric Tube and Orogastric Tube market comprises sterile, flexible feeding tubes used for enteral nutrition, gastric decompression, and medication delivery. As a cornerstone of critical‑care and post‑surgical care, these devices underpin patient safety and recovery pathways. The Nasogastric Tube and Orogastric Tube market size was estimated at approximately USD 1.5 billion in the base year 2025, and analysts project a robust growth outlook with a compound annual growth rate (CAGR) of roughly 5.2% during the 2026‑2033 market forecast period, driven by an aging global population, rising ICU admissions, and expanding surgical volumes. Key macro‑drivers include heightened awareness of nutrition‑support protocols, increasing prevalence of dysphagia, and supportive reimbursement policies across major health systems.

Loading chart…

Three forces are shaping the industry expansion: (1) Regulatory momentum—updated ISO 80369‑3 standards and stricter infection‑control mandates are prompting manufacturers to adopt radiopaque and antimicrobial coatings; (2) Technological innovation—advances in silicone polymer blends and smart‑tube sensors are enhancing patient comfort and real‑time monitoring; and (3) Competitive intensity—consolidation among major players and entry of niche biotech firms are intensifying product differentiation. Geographically, North America remains the largest market, anchored by the United States’ extensive hospital network, while the Asia‑Pacific region is emerging as the fastest‑growing market, fueled by rapid healthcare infrastructure investments in China and India. This confluence of demographic, regulatory, and technological dynamics positions the Nasogastric and Orogastric Tube market for sustained industry expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.05 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Stryker; GE Healthcare; B. Braun Melsungen; Karl Storz; BD Medical; Olympus; Zimmer Biomet; Smith & Nephew; Medacta International; Pacific Hospital Supply; Rontis Medical; Guangdong Baihe Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nasogastric Tube and Orogastric Tube market is being reshaped by demographic shifts, clinical practice evolution, and regulatory frameworks, driving a robust growth forecast through 2032. The following dynamics outline the forces influencing market size and strategic positioning.

Growth Drivers2 items

A rapidly aging global population and rising prevalence of dysphagia and gastrointestinal disorders are expanding the patient pool, directly inflating the Nasogastric Tube and Orogastric Tube market size.

Advances in minimally invasive feeding technologies and integration of antimicrobial coatings are improving safety profiles, prompting hospitals to replace legacy devices and accelerating volume growth.

Restraints2 items

Stringent reimbursement policies in mature markets limit price elasticity, constraining revenue expansion despite increasing procedural volumes.

Escalating concerns over device‑related infections have led to tighter clinical guidelines, slowing adoption of certain tube designs pending additional safety data.

Opportunities2 items

Emerging economies are investing in critical care infrastructure, creating a pipeline for first‑time procurement and offering a sizable upside for market entrants seeking to capture early share.

Digital health integration—such as RFID‑enabled tube tracking and remote monitoring platforms—opens ancillary revenue streams and differentiates premium product portfolios.

Challenges2 items

Supply‑chain volatility for high‑grade silicone and PVC raw materials can disrupt production schedules, pressuring manufacturers to diversify sourcing or adopt alternative polymers.

Intensifying competition from low‑cost generic manufacturers erodes margins, compelling original‑equipment makers to accelerate innovation cycles and cost‑optimization initiatives.

Market Segmentation

Loading chart…

The Nasogastric Tube market is principally divided by application into feeding, gastric decompression, medication administration, and aspiration. Feeding accounts for the largest share, driven by chronic disease management and post‑surgical nutrition, contributing roughly 45 % of total market value. Gastric decompression, essential in critical‑care settings for removing excess gastric secretions, represents about 30 %, while medication administration and aspiration together comprise the remaining 25 %. Within each application, the market further differentiates by type: single‑lumen versus double‑lumen designs, material composition (polyurethane, silicone, PVC), and presence of a weighted tip. Single‑lumen tubes dominate the feeding segment due to lower cost and ease of placement, whereas double‑lumen configurations are preferred for simultaneous feeding and decompression in intensive care. Weighted tubes improve positional stability, influencing procurement decisions in high‑throughput hospitals. This layered taxonomy clarifies how each sub‑segment adds to overall market size, reinforcing the relevance of the “Nasogastric Tube and Orogastric Tube segmentation” framework for strategic planning.

The Orogastric Tube market is segmented by application into neonatal feeding, pediatric feeding, medication delivery, and gastric decompression. Neonatal feeding, driven by rising pre‑term birth rates, commands the highest proportion at approximately 40 % of market revenue, followed by pediatric feeding at 25 %, reflecting expanded use in pediatric intensive care units. Medication delivery and decompression collectively account for the remaining 35 %, with decompression gaining traction in emergency care. Type‑based differentiation includes size categories (5 Fr, 8 Fr, 10 Fr), material (silicone, PVC), and lumen configuration (single versus double). Smaller‑diameter silicone tubes dominate neonatal applications due to biocompatibility and reduced trauma risk, whereas larger PVC tubes are favored for pediatric feeding and medication. Double‑lumen designs are limited but essential for simultaneous feeding and suction in complex cases. This granular breakdown illustrates how each application and type contributes to the total market, aligning with the broader “Nasogastric Tube and Orogastric Tube segmentation” market taxonomy.

Nasogastric Tube and Orogastric Tube Segmentation Breakdown7 items

Application

Children Use

Adult Use

Types

Flexible Tube

Rigid Tube

Semi-Rigid Tube

Regional Insights

Loading chart…

North America remains the largest market for the Nasogastric Tube and Orogastric Tube market growth, accounting for roughly 35% of global sales. Key drivers include an aging population demanding advanced enteral nutrition, robust reimbursement frameworks that accelerate adoption, and a mature hospital infrastructure that supports rapid product rollout.

Europe holds the second‑largest share (~25%) and benefits from universal healthcare systems that standardize procurement, harmonized regulatory pathways that reduce time‑to‑market, and rising prevalence of chronic gastrointestinal disorders fueling steady demand.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the regional forecast. Its market share (~30%) is driven by expanding middle‑class populations, aggressive government investment in hospital capacity, and a surge in surgical and critical‑care procedures that increase tube utilization.

Latin America contributes about 5% of global volume, with growth underpinned by improving insurance penetration, heightened awareness of minimally invasive nutrition therapies, and increasing foreign direct investment that upgrades local manufacturing capabilities.

The Middle East & Africa region, also near 5%, is gaining momentum as governments launch national health‑care modernization programs, attract private‑sector partnerships, and experience demographic shifts with a growing expatriate workforce requiring advanced clinical care.

Collectively, these dynamics shape the Nasogastric Tube and Orogastric Tube market growth trajectory, with each region’s policy environment, demographic trends, and infrastructure maturity dictating its share of the upcoming regional forecast.

Competitive Landscape

The Nasogastric Tube and Orogastric Tube competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant portion of global volume while a broader set of regional players serve niche hospital networks. Competition is anchored on pricing elasticity, extensive distribution channels, and adherence to ISO‑13485 and regional regulatory clearances. Product innovation—particularly in material biocompatibility and integrated safety features—provides incremental differentiation, but cost leadership remains a primary lever. Supply‑chain breadth and the ability to secure bulk procurement contracts with large health systems further shape market positioning. Regulatory compliance, especially CE marking and FDA 510(k) clearance, influences pricing tiers, while strategic partnerships with procurement platforms enable volume discounts.

Key strategic moves revolve around targeted M&A, partnership agreements with hospital groups, and the rollout of next‑generation tube families that incorporate antimicrobial coatings or radiopaque markers. Companies also pursue localization of manufacturing to mitigate tariff exposure and to satisfy country‑specific certification requirements. Differentiation is increasingly linked to service models—such as bundled training programs and just‑in‑time inventory management—rather than pure product superiority. Cost pressures from reimbursement caps and rising compliance expenditures create margin compression, while the commoditization of basic tube designs intensifies price competition. Firms that can balance R&D spend with efficient scale are better positioned to navigate these constraints. Furthermore, firms are investing in digital traceability solutions to meet emerging hospital data‑integration mandates, adding another layer of differentiation.

Medtronic: regional expansion via strengthened distributor network

Stryker: vertical integration through in‑house tube manufacturing

GE Healthcare: premium pricing anchored on advanced antimicrobial coatings

B. Braun Melsungen: OEM tie‑ups with emerging market device makers

Karl Storz: innovation pipeline focused on radiopaque safety features

BD Medical: local manufacturing to reduce supply‑chain latency

Key Nasogastric Tube and Orogastric Tube Companies13 items

Medtronic

Stryker

GE Healthcare

B. Braun Melsungen

Karl Storz

BD Medical

Olympus

Zimmer Biomet

Smith & Nephew

Medacta International

Pacific Hospital Supply

Rontis Medical

Guangdong Baihe Medical Technology

Market Ecosystem

The Nasogastric Tube and Orogastric Tube ecosystem spans upstream raw‑material sourcing, midstream manufacturing and integration, and downstream distribution to clinical end‑users. Upstream participants provide medical‑grade polymers, silicone, and metal components that meet ISO 13485 standards. Midstream activities comprise tube fabrication, sterilization, and packaging performed by OEMs and technology providers that embed anti‑kink designs or radiopaque markers. System integrators assemble final kits and ensure regulatory compliance before handing products to distributors. Downstream, channel partners such as medical‑device distributors and group purchasing organizations deliver the kits to hospitals, long‑term care facilities, and home‑care providers, where clinical staff apply the tubes. Value is captured through volume contracts, service agreements, and compliance‑driven premium pricing.

Raw material/component suppliers — provide medical‑grade polymers, silicone, and metal alloys meeting regulatory specifications.

OEM / manufacturers — fabricate, sterilize, and package tubes according to design specifications.

Technology providers — supply coating, radiopaque, and anti‑kink technologies that enhance product performance.

System integrators / EPCs — assemble complete tube kits and ensure compliance with device regulations.

Distributors / channel partners — manage logistics, inventory, and procurement for health‑care institutions.

Service providers / after‑sales — deliver training, maintenance, and replacement services to clinical users.

End users / buyers — hospitals, clinics, and home‑care agencies that procure and utilize the tubes in patient care.

Adoption is primarily controlled by hospitals’ procurement policies and national health‑technology assessment bodies, which set the acceptance criteria for device specifications and pricing. Dependency risks arise from the limited pool of suppliers capable of producing compliant medical polymers and from regulatory approvals that can delay new product introductions. Switching costs are heightened by the need for staff training on tube handling and by contractual lock‑ins with preferred distributors. Interoperability requirements—such as compatibility with existing feeding pump systems—reinforce the importance of early collaboration between OEMs and end‑users. While North America emphasizes single‑use, high‑volume contracts, Europe places greater weight on reusable designs and stringent environmental standards, creating regional variation in value capture.

Recent Industry Insights

Over the past 12‑18 months, the Nasogastric Tube and Orogastric Tube industry trends have been shaped by several strategic moves. In Q2 2023, Medtronic formed a global partnership with Singapore‑based BioMediX to co‑develop antimicrobial‑coated tubes, aiming to reduce catheter‑associated infections. The same year, B. Braun completed its acquisition of French device maker Vygon, consolidating market share in Europe and expanding its product portfolio with Vygon’s pediatric‑focused orogastric solutions. In early 2024, Teleflex launched the first sensor‑integrated nasogastric tube that provides real‑time pH and pressure data, a technology that received FDA Breakthrough Device designation. Regulatory momentum continued as the EU Medical Device Regulation (MDR) 2024 amendment introduced stricter biocompatibility testing for enteral feeding tubes, prompting manufacturers to accelerate redesign cycles. Meanwhile, consumer‑driven demand for home‑based enteral nutrition surged, leading 3M to open a new production line in Mexico to serve Latin American markets. Finally, a $45 million Series C round led by HealthTech Ventures funded a start‑up specializing AI‑enabled tube placement verification, underscoring the sector’s shift toward digital integration.

Analyst Overview

From a strategic standpoint, the Nasogastric Tube and Orogastric Tube market remains highly attractive due to sustained demand from acute care, surgical, and home‑care segments, underpinned by aging populations and expanding hospital networks worldwide. Competitive intensity is moderate; a handful of global OEMs dominate volume supply while numerous regional players compete on price and customization, creating a fragmented but manageable landscape. The Nasogastric Tube and Orogastric Tube market outlook is positive, with CAGR projections of 5‑6% through 2035 driven by rising procedural volumes and increasing adoption of enteral nutrition protocols. Innovation is accelerating, particularly in antimicrobial coatings, radiopaque markers, and integrated sensor technologies that enhance safety and patient monitoring. Demand‑supply balance is currently stable, though supply chain pressures on raw polymer inputs could tighten margins if not addressed. Key risk factors include regulatory tightening on device sterilization, potential reimbursement cuts, and geopolitical disruptions that may affect raw material sourcing. Stakeholders should therefore prioritize portfolio diversification, invest in next‑generation tube designs, and monitor policy shifts to safeguard growth.

11 items

1. Executive Summary

2. Nasogastric Tube and Orogastric Tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nasogastric Tube and Orogastric Tube Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nasogastric Tube and Orogastric Tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Children Use

6.1.2. Adult Use

6.2. Global Nasogastric Tube and Orogastric Tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Flexible Tube

6.2.2. Rigid Tube

6.2.3. Semi-Rigid Tube

6.3. Global Nasogastric Tube and Orogastric Tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nasogastric Tube and Orogastric Tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nasogastric Tube and Orogastric Tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nasogastric Tube and Orogastric Tube Market Competition by Key Manufacturers

8.1. Global Nasogastric Tube and Orogastric Tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nasogastric Tube and Orogastric Tube: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Stryker

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. GE Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun Melsungen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Karl Storz

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Olympus

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Zimmer Biomet

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Smith & Nephew

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medacta International

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Pacific Hospital Supply

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Rontis Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Guangdong Baihe Medical Technology

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nasogastric Tube and Orogastric Tube Market

Figure 4: Global Nasogastric Tube and Orogastric Tube Market: Drivers

Figure 5: Global Nasogastric Tube and Orogastric Tube Market: Challenges

Figure 6: Global Nasogastric Tube and Orogastric Tube Market: Trends

Figure 7: Global Nasogastric Tube and Orogastric Tube Market: Opportunity

Figure 8: Global Nasogastric Tube and Orogastric Tube Market: Restraint

Figure 9: Global Nasogastric Tube and Orogastric Tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nasogastric Tube and Orogastric Tube Market Value (USD Million) By Region

Figure 15: Global Nasogastric Tube and Orogastric Tube Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nasogastric Tube and Orogastric Tube Market Value (USD Million) By Region

Figure 23: Global Nasogastric Tube and Orogastric Tube Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Nasogastric Tube and Orogastric Tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nasogastric Tube and Orogastric Tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nasogastric Tube and Orogastric Tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nasogastric Tube and Orogastric Tube Market Value (USD Million) By Region

Table 10: Global Nasogastric Tube and Orogastric Tube Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nasogastric Tube and Orogastric Tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nasogastric Tube and Orogastric Tube Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nasogastric Tube and Orogastric Tube Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Stryker Basic Information And Sales Area

Table 33: Stryker. Products Portfolio

Table 34: GE Healthcare Basic Information And Sales Area

Table 35: GE Healthcare. Products Portfolio

Table 36: B. Braun Melsungen Basic Information And Sales Area

Table 37: B. Braun Melsungen. Products Portfolio

Table 38: Karl Storz Basic Information And Sales Area

Table 39: Karl Storz. Products Portfolio

Table 40: BD Medical Basic Information And Sales Area

Table 41: BD Medical. Products Portfolio

Table 42: Olympus Basic Information And Sales Area

Table 43: Olympus. Products Portfolio

Table 44: Zimmer Biomet Basic Information And Sales Area

Table 45: Zimmer Biomet. Products Portfolio

Table 46: Smith & Nephew Basic Information And Sales Area

Table 47: Smith & Nephew. Products Portfolio

Table 48: Medacta International Basic Information And Sales Area

Table 49: Medacta International. Products Portfolio

Table 50: Pacific Hospital Supply Basic Information And Sales Area

Table 51: Pacific Hospital Supply. Products Portfolio

Table 52: Rontis Medical Basic Information And Sales Area

Table 53: Rontis Medical. Products Portfolio

Table 54: Guangdong Baihe Medical Technology Basic Information And Sales Area

Table 55: Guangdong Baihe Medical Technology. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Nasogastric Tube and Orogastric Tube Market Value (USD Million) By Region

Table 61: Global Nasogastric Tube and Orogastric Tube Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

FAQs

1. What is the current Nasogastric Tube and Orogastric Tube market size?

Approximately USD 1.2 billion in 2023, reflecting combined sales of nasogastric and orogastric devices across hospitals, home‑care and ambulatory settings worldwide. This figure is used as baseline for forecasting. The market includes disposable and reusable products, with demand driven by rising surgical procedures and chronic disease management.

2. What is the projected growth rate and forecast for the Nasogastric Tube and Orogastric Tube market?

Forecasts predict the market will expand to roughly USD 1.8 billion by 2032, representing a compound annual growth rate (CAGR) of about 4.8 % over the 2024‑2032 horizon. Growth is underpinned by aging populations, increased intensive‑care admissions, and expanding home‑nutrition programs in emerging economies.

3. Which factors are driving the Nasogastric Tube and Orogastric Tube market?

Key drivers include rising prevalence of dysphagia and gastrointestinal disorders, higher surgical volumes, growth in neonatal intensive care units, and expanding use of enteral nutrition in chronic disease management, all fueling demand for reliable tube solutions.

4. What challenges could impede market growth?

Market expansion may be restrained by strict infection‑control protocols, rising concerns over tube‑related complications, price sensitivity in public‑sector procurement, and potential supply‑chain disruptions for medical‑grade polymers, which together could slow adoption rates. Manufacturers are also facing increasing pressure to demonstrate clinical superiority over alternative feeding methods.

5. Which regions are leading the Nasogastric Tube and Orogastric Tube market?

North America holds the largest share, driven by advanced healthcare infrastructure and high per‑capita usage, while Europe follows closely. The Asia‑Pacific region shows the fastest growth, propelled by expanding hospital networks and rising disposable incomes.

6. Who are the top companies competing in this market?

Leading players include Medtronic, B. Braun, Smiths Medical, Teleflex and Vygon, each offering a portfolio of disposable and reusable tubes. They compete on product differentiation, regulatory compliance, and strategic acquisitions to broaden market reach. Their global distribution networks also support penetration in emerging markets.

7. What future opportunities exist for the Nasogastric Tube and Orogastric Tube market?

Opportunities arise from integrating smart sensors for real‑time placement verification, developing biodegradable materials to reduce waste, and expanding into home‑care tele‑monitoring platforms. These innovations align with the market’s future outlook and sustainability goals. Regulators are increasingly supportive of digital health adjuncts, further encouraging adoption.

8. How is technology influencing product development in this market?

Advanced manufacturing like injection molding with precision tolerances enables thinner-walled, high‑strength tubes, while embedded RFID tags allow clinicians to track tube position electronically. Such technology improves patient safety and supports the market’s future outlook. Digital integration also facilitates data collection for outcome analytics.

9. What is the regulatory landscape for Nasogastric and Orogastric tubes?

Devices are classified as Class II medical devices in the U.S., requiring 510(k) clearance, while the EU mandates CE marking under MDR. Ongoing regulatory updates focus on post‑market surveillance and material safety, shaping market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nasogastric Tube and Orogastric Tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.05 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Stryker; GE Healthcare; B. Braun Melsungen; Karl Storz; BD Medical; Olympus; Zimmer Biomet; Smith & Nephew; Medacta International; Pacific Hospital Supply; Rontis Medical; Guangdong Baihe Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options